Shanghai Cell Therapy Group Funding: $134M Raised, Series C

Shanghai Cell Therapy Group funding overview

Shanghai Cell Therapy Group is based in Shanghai, China. Shanghai Cell Therapy Group has raised $134M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in December 2018. The round record for Shanghai Cell Therapy Group runs through 2018; nothing later has been disclosed. Investors on record include China Pacific Insurance, Haier Capital, China Industrial Asset Management Limited, Legend Capital, Anting People's Government, Ningbo Yuanhui. 6 distinct backers are named across the disclosed rounds.

Shanghai Cell Therapy Group at a glance

Total raised: $134M
Latest round: Series C
Latest round date: December 2018
Headquarters: Shanghai, China
Notable investors: China Pacific Insurance, Haier Capital, China Industrial Asset Management Limited, Legend Capital, Anting People's Government, Ningbo Yuanhui

Frequently asked about Shanghai Cell Therapy Group funding

How much has Shanghai Cell Therapy Group raised?: Shanghai Cell Therapy Group has raised $134M in total disclosed funding across the rounds on record.
Who has invested in Shanghai Cell Therapy Group?: China Pacific Insurance, Haier Capital, China Industrial Asset Management Limited, Legend Capital, Anting People's Government, Ningbo Yuanhui are named among the investors backing Shanghai Cell Therapy Group.
What was the latest Shanghai Cell Therapy Group funding round?: The most recent disclosed round is a Series C, announced in December 2018.
Where is Shanghai Cell Therapy Group based?: Shanghai Cell Therapy Group is based in Shanghai, China.
When did Shanghai Cell Therapy Group last raise?: The last disclosed Shanghai Cell Therapy Group round closed in December 2018 at Series C.

Every Shanghai Cell Therapy Group figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.

Shanghai Cell Therapy Group Funding: $134M Raised, Series C

Shanghai Cell Therapy Group funding overview

Shanghai Cell Therapy Group at a glance

Frequently asked about Shanghai Cell Therapy Group funding

Companies related to Shanghai Cell Therapy Group (19)

Browse related funding lists (6)